Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety

C. Hawley, M. Turner, M.A. Latif, V. Curtis, P.T. Saleem, K. Wilton

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety'. Together they form a unique fingerprint.

    Medicine & Life Sciences